Latest Regulation News

Gibb River Diamonds advances key permits for its Edjudina Gold Project, aiming to begin mining at the Neta Prospect by August 2025 with minimal financial risk.

ECS Botanics has launched the globally acclaimed Terphogz™ cannabis strains, including The Original Z™, into the Australian medicinal market, marking a strategic expansion of its premium product portfolio.

BlinkLab has secured US Institutional Review Board approval to proceed with the main phase of its FDA 510(k) trial for an AI-powered autism diagnostic tool, marking a key step toward regulatory clearance.

Finder Energy has opened a new office in Dili to support its KTJ oil fields project, signalling a strategic push to embed local operations and partnerships in Timor-Leste.

Dalrymple Bay Infrastructure Limited (DBI) reports robust FY-24 results, underpinned by stable take-or-pay contracts and a $366 million capital program, while advancing its 8X capacity expansion project.

PointsBet Holdings Limited has updated its FY25 financial outlook, signalling that both revenue and EBITDA are expected to land at the bottom of previously forecasted ranges.

Silk Logistics Holdings and DP World Australia have agreed to push back the deadline for their acquisition deal, awaiting a key regulatory decision from the ACCC.

Microba Life Sciences has announced a $14.5 million capital raising, including a $2 million fully underwritten Securities Purchase Plan (SPP) and a $12.5 million Placement, aimed at fast-tracking commercialisation of its microbiome diagnostic tests in Australia and the UK.

State Street Global Advisors has announced a substantial cash distribution for the SPDR S&P/ASX 200 ESG ETF, reflecting the fund’s income and tax attributes for the year ending June 2025.

State Street Global Advisors has announced the June 2025 distribution for the SPDR Dow Jones Global Real Estate ESG Tilted ETF, detailing income components and tax credits. Investors can expect a mix of cash and franking credits, with key dates for trading and reinvestment outlined.

Sprintex secures a key deposit from Mest Water to develop new compressors for mobile manure processing systems, leveraging a Dutch government subsidy aimed at thousands of small farms.

Percheron Therapeutics has licensed HMBD-002, a promising immuno-oncology monoclonal antibody targeting VISTA, from Hummingbird Bioscience, marking a strategic pivot after recent setbacks. The company plans to initiate phase II trials in 2026, aiming to advance this novel cancer therapy toward commercialisation.